Indian-American cardiologist invests $60 million in medical device company

The investment by the Indian American cardiologist will pave way for clinical studies

Pharmaceuticals, drugs, pharma industry, medical, health, lab
Press Trust of India Houston
Last Updated : Oct 12 2018 | 11:37 AM IST

An Indian-American cardiologist and entrepreneur has invested $60 million in a medical company that will support clinical trial on cardiac devices to replace stent.

Dr Kiran Patel's investment is for the Concept Medical Inc, a Florida-based medical device company's Investigational Device Exemption (IDE) for the world's first sirolimus-coated balloon.

Sirolimus balloon catheter is a drug-coated balloon, which is a replacement of the stent. If a stent cannot be placed in human body or doesn't have a good outcome, then sirolimus balloon is used.

According to the company, the investment by the Indian American cardiologist will pave way for clinical studies to reduce risk of heart blockages.

Patel's investment will pay for clinical studies on cardiac devices coated with a substance that reduces the risk of heart blockages and the length of time a patient needs to take blood thinners, according to a statement issued by the company.

Noting that cardiovascular diseases represents 31 per cent of all global deaths, Patel said that his contribution will help towards the healthcare of millions of people around the world.

"I am excited to be a part of CMI whose research & innovative technologies will meet a major unmet need in patients with diabetes and cardiovascular diseases. This venture enables me to contribute to the millions of hearts beating around the world," Patel was quoted as saying in the release.

A portion of the funds will also be utilised to bolster the manufacturing operations to meet the increasing demand for their products globally.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 12 2018 | 10:35 AM IST

Next Story